Literature DB >> 28812650

Autosomal recessive cone-rod dystrophy can be caused by mutations in the ATF6 gene.

Anna Skorczyk-Werner1, Wei-Chieh Chiang2, Anna Wawrocka1, Katarzyna Wicher1, Małgorzata Jarmuż-Szymczak3, Magdalena Kostrzewska-Poczekaj3, Aleksander Jamsheer1,4, Rafał Płoski5, Małgorzata Rydzanicz5, Dorota Pojda-Wilczek6, Nicole Weisschuh7, Bernd Wissinger7, Susanne Kohl7, Jonathan H Lin2, Maciej R Krawczyński1,4.   

Abstract

Inherited retinal dystrophies (IRDs) are clinically and genetically highly heterogeneous, making clinical diagnosis difficult. The advances in high-throughput sequencing (ie, panel, exome and genome sequencing) have proven highly effective on defining the molecular basis of these disorders by identifying the underlying variants in the respective gene. Here we report two siblings affected by an IRD phenotype and a novel homozygous c.1691A>G (p.(Asp564Gly)) ATF6 (activating transcription factor 6A) missense substitution identified by whole exome sequencing analysis. The pathogenicity of the variant was confirmed by functional analyses done on patients' fibroblasts and on recombinant p.(Asp564Gly) protein. The ATF6Asp564Gly/Asp564Gly variant shows impaired production of the ATF6 cleaved transcriptional activator domain in response to endoplasmic reticulum stress. Detailed phenotypic examination revealed extinguished cone responses but also decreased rod responses together with the ability to discriminate some colours suggestive rather for cone-rod dystrophy than achromatopsia.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28812650      PMCID: PMC5643965          DOI: 10.1038/ejhg.2017.131

Source DB:  PubMed          Journal:  Eur J Hum Genet        ISSN: 1018-4813            Impact factor:   4.246


  22 in total

1.  Activation of mammalian unfolded protein response is compatible with the quality control system operating in the endoplasmic reticulum.

Authors:  Satomi Nadanaka; Hiderou Yoshida; Fumi Kano; Masayuki Murata; Kazutoshi Mori
Journal:  Mol Biol Cell       Date:  2004-03-12       Impact factor: 4.138

2.  Standard for clinical electroretinography (2004 update).

Authors:  Michael F Marmor; Graham E Holder; Mathias W Seeliger; Shuichi Yamamoto
Journal:  Doc Ophthalmol       Date:  2004-03       Impact factor: 2.379

3.  CNGB3 achromatopsia with progressive loss of residual cone function and impaired rod-mediated function.

Authors:  Naheed Wali Khan; Bernd Wissinger; Susanne Kohl; Paul A Sieving
Journal:  Invest Ophthalmol Vis Sci       Date:  2007-08       Impact factor: 4.799

4.  Progressive loss of cones in achromatopsia: an imaging study using spectral-domain optical coherence tomography.

Authors:  Alberta A H J Thiadens; Ville Somervuo; L Ingeborgh van den Born; Susanne Roosing; Mary J van Schooneveld; Robert W A M Kuijpers; Norka van Moll-Ramirez; Frans P M Cremers; Carel B Hoyng; Caroline C W Klaver
Journal:  Invest Ophthalmol Vis Sci       Date:  2010-06-23       Impact factor: 4.799

5.  Mutations in the unfolded protein response regulator ATF6 cause the cone dysfunction disorder achromatopsia.

Authors:  Susanne Kohl; Ditta Zobor; Wei-Chieh Chiang; Nicole Weisschuh; Jennifer Staller; Irene Gonzalez Menendez; Stanley Chang; Susanne C Beck; Marina Garcia Garrido; Vithiyanjali Sothilingam; Mathias W Seeliger; Franco Stanzial; Francesco Benedicenti; Francesca Inzana; Elise Héon; Ajoy Vincent; Jill Beis; Tim M Strom; Günther Rudolph; Susanne Roosing; Anneke I den Hollander; Frans P M Cremers; Irma Lopez; Huanan Ren; Anthony T Moore; Andrew R Webster; Michel Michaelides; Robert K Koenekoop; Eberhart Zrenner; Randal J Kaufman; Stephen H Tsang; Bernd Wissinger; Jonathan H Lin
Journal:  Nat Genet       Date:  2015-06-01       Impact factor: 38.330

6.  Does p.Q247X in TRIM63 cause human hypertrophic cardiomyopathy?

Authors:  Rafal Ploski; Agnieszka Pollak; Sonja Müller; Maria Franaszczyk; Ewa Michalak; Joanna Kosinska; Piotr Stawinski; Mateusz Spiewak; Hubert Seggewiss; Zofia T Bilinska
Journal:  Circ Res       Date:  2014-01-17       Impact factor: 17.367

Review 7.  Endoplasmic reticulum stress in human photoreceptor diseases.

Authors:  Priscilla Chan; Julia Stolz; Susanne Kohl; Wei-Chieh Chiang; Jonathan H Lin
Journal:  Brain Res       Date:  2016-04-23       Impact factor: 3.252

8.  Clinical subtypes of cone-rod dystrophy.

Authors:  J P Szlyk; G A Fishman; K R Alexander; N S Peachey; D J Derlacki
Journal:  Arch Ophthalmol       Date:  1993-06

Review 9.  Cone rod dystrophies.

Authors:  Christian P Hamel
Journal:  Orphanet J Rare Dis       Date:  2007-02-01       Impact factor: 4.123

10.  Mutation of ATF6 causes autosomal recessive achromatopsia.

Authors:  Muhammad Ansar; Regie Lyn P Santos-Cortez; Muhammad Arif Nadeem Saqib; Fareeha Zulfiqar; Kwanghyuk Lee; Naeem Mahmood Ashraf; Ehsan Ullah; Xin Wang; Sundus Sajid; Falak Sher Khan; Muhammad Amin-ud-Din; Joshua D Smith; Jay Shendure; Michael J Bamshad; Deborah A Nickerson; Abdul Hameed; Saima Riazuddin; Zubair M Ahmed; Wasim Ahmad; Suzanne M Leal
Journal:  Hum Genet       Date:  2015-06-11       Impact factor: 4.132

View more
  17 in total

Review 1.  The unfolded protein response in metazoan development.

Authors:  Sahana Mitra; Hyung Don Ryoo
Journal:  J Cell Sci       Date:  2019-02-15       Impact factor: 5.285

Review 2.  ER stress and unfolded protein response in ocular health and disease.

Authors:  Heike Kroeger; Wei-Chieh Chiang; Julia Felden; Amanda Nguyen; Jonathan H Lin
Journal:  FEBS J       Date:  2018-06-20       Impact factor: 5.542

Review 3.  Small molecule strategies to harness the unfolded protein response: where do we go from here?

Authors:  Julia M D Grandjean; R Luke Wiseman
Journal:  J Biol Chem       Date:  2020-09-04       Impact factor: 5.157

Review 4.  Proteostasis and Beyond: ATF6 in Ischemic Disease.

Authors:  Christopher C Glembotski; Jessica D Rosarda; R Luke Wiseman
Journal:  Trends Mol Med       Date:  2019-05-08       Impact factor: 11.951

5.  The unfolded protein response regulator ATF6 promotes mesodermal differentiation.

Authors:  Heike Kroeger; Neil Grimsey; Ryan Paxman; Wei-Chieh Chiang; Lars Plate; Ying Jones; Peter X Shaw; JoAnn Trejo; Stephen H Tsang; Evan Powers; Jeffery W Kelly; R Luke Wiseman; Jonathan H Lin
Journal:  Sci Signal       Date:  2018-02-13       Impact factor: 8.192

6.  Pathomechanisms of ATF6-Associated Cone Photoreceptor Diseases.

Authors:  Wei-Chieh Jerry Chiang; Heike Kroeger; Lulu Chea; Jonathan H Lin
Journal:  Adv Exp Med Biol       Date:  2019       Impact factor: 2.622

7.  Multiexon deletion alleles of ATF6 linked to achromatopsia.

Authors:  Eun-Jin Lee; Wei-Chieh Jerry Chiang; Heike Kroeger; Chloe Xiaoke Bi; Daniel L Chao; Dorota Skowronska-Krawczyk; Rebecca R Mastey; Stephen H Tsang; Leon Chea; Kyle Kim; Scott R Lambert; Julia Md Grandjean; Britta Baumann; Isabelle Audo; Susanne Kohl; Anthony T Moore; R Luke Wiseman; Joseph Carroll; Jonathan H Lin
Journal:  JCI Insight       Date:  2020-04-09

8.  ATF6 is essential for human cone photoreceptor development.

Authors:  Heike Kroeger; Julia M D Grandjean; Wei-Chieh Jerry Chiang; Daphne D Bindels; Rebecca Mastey; Jennifer Okalova; Amanda Nguyen; Evan T Powers; Jeffery W Kelly; Neil J Grimsey; Michel Michaelides; Joseph Carroll; R Luke Wiseman; Jonathan H Lin
Journal:  Proc Natl Acad Sci U S A       Date:  2021-09-28       Impact factor: 12.779

9.  Non-syndromic inherited retinal diseases in Poland: Genes, mutations, and phenotypes.

Authors:  Anna M Tracewska; Beata Kocyła-Karczmarewicz; Agnieszka Rafalska; Joanna Murawska; Joanna Jakubaszko-Jabłónska; Małgorzata Rydzanicz; Piotr Stawiński; Elżbieta Ciara; Beata S Lipska-Ziętkiewicz; Muhammad Imran Khan; Frans P M Cremers; Rafał Płoski; Krystyna H Chrzanowska
Journal:  Mol Vis       Date:  2021-07-16       Impact factor: 2.367

10.  Novel variants identified with next-generation sequencing in Polish patients with cone-rod dystrophy.

Authors:  Anna Wawrocka; Anna Skorczyk-Werner; Katarzyna Wicher; Zuzanna Niedziela; Rafal Ploski; Malgorzata Rydzanicz; Maciej Sykulski; Jaroslaw Kociecki; Nicole Weisschuh; Susanne Kohl; Saskia Biskup; Bernd Wissinger; Maciej R Krawczynski
Journal:  Mol Vis       Date:  2018-04-26       Impact factor: 2.367

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.